发明授权
- 专利标题: 3,6-dihydro-2-oxo-6H-1,3,4,-thiadiazine derivatives
- 专利标题(中): 3,6-二氢-2-氧代-6H-1,3,4,噻二嗪衍生物
-
申请号: US12094544申请日: 2006-10-25
-
公开(公告)号: US07534785B2公开(公告)日: 2009-05-19
- 发明人: Oliver Schadt , Dieter Dorsch , Melanie Schultz , Andree Blaukat
- 申请人: Oliver Schadt , Dieter Dorsch , Melanie Schultz , Andree Blaukat
- 申请人地址: DE Darmstadt
- 专利权人: Merck Patent Gesellschaft
- 当前专利权人: Merck Patent Gesellschaft
- 当前专利权人地址: DE Darmstadt
- 代理机构: Millen, White, Zelano & Branigan, P.C.
- 优先权: DE102005055355 20051121
- 国际申请: PCT/EP2006/010286 WO 20061025
- 国际公布: WO2007/057093 WO 20070524
- 主分类号: C07D285/18
- IPC分类号: C07D285/18 ; A61K31/54 ; A61P35/00
摘要:
Compounds of the formula I, in which R1, R2, Q and B have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.
公开/授权文献
- US20080306052A1 3, 6-Dihydro-2-Oxo-6H-1,3,4,-Thiadiazine Derivatives 公开/授权日:2008-12-11